Mammalian sphingoid bases: Biophysical, physiological and pathological properties

Sphingoid bases encompass a group of long chain amino alcohols which form the essential structure of sphingolipids. Over the last years, these amphiphilic molecules were moving more and more into the focus of biomedical research due to their role as bioactive molecules. In fact, free sphingoid bases interact with specific receptors and target molecules, and have been associated with numerous biological and physiological processes. In addition, they can modulate the biophysical properties of biological membranes. Several human diseases are related to pathological changes in the structure and metabolism of sphingoid bases. Yet, the mechanisms underlying their biological and pathophysiological actions remain elusive. Within this review, we aimed to summarize the current knowledge on the biochemical and biophysical properties of the most common sphingoid bases and to discuss their importance in health and disease

Intensive care utilisation and outcomes after high-risk surgery in Scotland: a population based cohort study.

Chief Scientist’s Office Scotland (grant no. CHZ/821/4)

Effect of ethrel and nitrogen on nitrate reductase activity, photosynthesis, biomass and yield of mustard (Brassica juncea L. Czern and Coss)

      The plants of mustard (Brassica juncea L. Czern and Coss; cultivar Alankar) were treated with 200 µL/L ethrel (2-chloro ethyl phosphonic acid) at flowering stage (60 d after sowing) along with basal application of nitrogen 40, 60, and 80 kg N ha-1. Effect of ethrel and nitrogen on leaf area index (LAI), net photosynthetic rate (PN), nitrate reductase (NR) activity and plant dry mass were recorded at 80 and 100 d after sowing. At harvest pods plant-1, 1000 seed mass and seed yield were recorded. Ethrel 200 µL/L x 80 kg N ha-1 treatment enhanced all the characteristics studied during the experiment

Neutronic Design and Measured Performance of the Low Energy Neutron Source (LENS) Target Moderator Reflector Assembly

The Low Energy Neutron Source (LENS) is an accelerator-based pulsed cold neutron facility under construction at the Indiana University Cyclotron Facility (IUCF). The idea behind LENS is to produce pulsed cold neutron beams starting with ~MeV neutrons from (p,n) reactions in Be which are moderated to meV energies and extracted from a small solid angle for use in neutron instruments which can operate efficiently with relatively broad (~1 msec) neutron pulse widths. Although the combination of the features and operating parameters of this source is unique at present, the neutronic design possesses several features similar to those envisioned for future neutron facilities such as long-pulsed spallation sources (LPSS) and very cold neutron (VCN) sources. We describe the underlying ideas and design details of the target/moderator/reflector system (TMR) and compare measurements of its brightness, energy spectrum, and emission time distribution under different moderator configurations with MCNP simulations. Brightness measurements using an ambient temperature water moderator agree with MCNP simulations within the 20% accuracy of the measurement. The measured neutron emission time distribution from a solid methane moderator is in agreement with simulation and the cold neutron flux is sufficient for neutron scattering studies of materials. We describe some possible modifications to the existing design which would increase the cold neutron brightness with negligible effect on the emission time distribution.Comment: This is a preprint version of an article which has been published in Nuclear Instruments and Methods in Physics Research A 587 (2008) 324-341. http://dx.doi.org/10.1016/j.nima.2007.12.04

Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood appr

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

A proportion of patients infected with severe acute respiratory syndrome coronavirus 2 experience a range of neuropsychiatric symptoms months after infection, including cognitive deficits, depression and anxiety. The mechanisms underpinning such symptoms remain elusive. Recent research has demonstrated that nervous system injury can occur during COVID-19. Whether ongoing neural injury in the months after COVID-19 accounts for the ongoing or emergent neuropsychiatric symptoms is unclear. Within a large prospective cohort study of adult survivors who were hospitalized for severe acute respiratory syndrome coronavirus 2 infection, we analysed plasma markers of nervous system injury and astrocytic activation, measured 6 months post-infection: neurofilament light, glial fibrillary acidic protein and total tau protein. We assessed whether these markers were associated with the severity of the acute COVID-19 illness and with post-acute neuropsychiatric symptoms (as measured by the Patient Health Questionnaire for depression, the General Anxiety Disorder assessment for anxiety, the Montreal Cognitive Assessment for objective cognitive deficit and the cognitive items of the Patient Symptom Questionnaire for subjective cognitive deficit) at 6 months and 1 year post-hospital discharge from COVID-19. No robust associations were found between markers of nervous system injury and severity of acute COVID-19 (except for an association of small effect size between duration of admission and neurofilament light) nor with post-acute neuropsychiatric symptoms. These results suggest that ongoing neuropsychiatric symptoms are not due to ongoing neural injury